Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Immunol Curr Res 2024,

Targeting Immune Checkpoints: Advancements in Cancer Immunotherapy

Chukwuemeka M*
Department of Primary Care and Public Health, Imperial College London, United Kingdom
*Corresponding Author : Chukwuemeka M, Department of Primary Care and Public Health, Imperial College London, United Kingdom, Email: mchuk3e@gmail.com

Received Date: Mar 01, 2024 / Published Date: Mar 31, 2024

Abstract

In recent years, cancer immunotherapy has emerged as a promising approach for treating various malignancies. Among the diverse strategies within this field, targeting immune checkpoints has gained significant attention due to its ability to unleash the body's immune system against tumor cells. This mini-review highlights the recent advancements in immune checkpoint inhibitors and novel strategies in cancer immunotherapy.

Citation: Chukwuemeka M (2024) Targeting Immune Checkpoints: Advancementsin Cancer Immunotherapy. Immunol Curr Res, 8: 191.

Copyright: © 2024 Chukwuemeka M. This is an open-access article distributedunder the terms of the Creative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.

Top